TITLE

Coagulación

AUTHOR(S)
Reyes Velászquez, Joel Oma; Ríos Alcántara, José Manuel
PUB. DATE
October 2010
SOURCE
Medicina Oral (16656024);2010, Vol. 12 Issue 4, p154
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
62006090

 

Related Articles

  • Chapter 15: Overview of Hemostasis and Platelet Physiology. Castellone, Donna // Hematology in Practice;2007, p229 

    Chapter 15 of the book "Hematology in Practice" is presented. It offers an overview of the systems involved in hemostasis. It traces the history of the study of blood coagulation. It discusses coagulation, its role in hemostasis and the two major systems of hemostasis. It explains the mechanism...

  • RE-OPERATIONS FOR BLEEDING IN CARDIAC SURGERY: TREATMENT STRATEGY. Gwozdziewicz, Marek; Olsak, Peter // Biomedical Papers of the Medical Faculty of Palacky University i;2008, Vol. 152 Issue 1, p159 

    Aims: Cardiac surgery patients are prone to bleeding postoperatively owing to the extensive sternotomy wound, multiple vessel and heart sutures, and disorders of hemostasis. In this study we retrospectively analyzed the outcomes for all patients in our department who were re-operated for...

  • Fisiología de la coagulación. Flores-Rivera, Oscar Iván; Ramírez-Morales, Karina; Meza-Márquez, José Martín; Nava-López, Jorge Arturo // Revista Mexicana de Anestesiologia;oct-dic2014 suppl. 2, Vol. 37, pS382 

    Hemostasis is the process that maintains the integrity of a closed, high-pressure circulatory system after vascular damage. For study purpose is divided into primary and secondary. Primary hemostasis refers to the processes by which the platelet plug is formed through adhesion, activation,...

  • Assays of different aspects of haemostasis -- what do they measure? Tynngård, Nahreen; Lindahl, Tomas L.; Ramström, Sofia // Thrombosis Journal;2015, Vol. 13 Issue 1, p1 

    Haemostasis is a complex process affected by many factors including both cellular and plasma components. It is a multistep process starting with platelet adhesion to damaged endothelium and ending in clot fibrinolysis. There are several methods available to study different aspects of haemostasis...

  • The Hemostatic System. Stassen, J. M.; Amout, J.; Deckmyn, H. // Current Medicinal Chemistry;Sep2004, Vol. 11 Issue 17, p2245 

    The hemostatic system comprises platelet aggregation, coagulation and fibrinolysis also termed primary, secondary and tertiary hemostasis. From the platelet transcriptome 6000 mRNA species and represent receptors, ion channels, signalling molecules, kinases, phosphatases, and structural,...

  • Therapieoptionen der perioperativ erworbenen Thrombozytopathie. Weber, C. F.; Schneider, A. C.; Kirschning, T.; Hofstetter, C.; Zacharowski, K.; Görlinger, K. // Anaesthesist;Sep2009, Vol. 58 Issue 9, p931 

    Increased intra-operative and postoperative blood loss might be caused by acquired platelet function disorders. In particular because conventional coagulation analyses and platelet count fail to detect impaired platelet function, implementation of bedside-tests for platelet function in the...

  • Development of North American Consensus Guidelines for Medical Laboratories That Perform and Interpret Platelet Function Testing Using Light Transmission Aggregometry. Hayward, Catherine P. M.; Moffat, Karen A.; Raby, Anne; Israels, Sara; Plumhoff, Elizabeth; Flynn, Greg; Zehnder, James L. // American Journal of Clinical Pathology;Dec2010, Vol. 134 Issue 6, p955 

    Platelet function testing is important for the diagnostic evaluation of common and rare bleeding disorders. Our study goals were to promote best practices and reduce unnecessary testing variances by developing North American guidelines on platelet function testing. Guidelines were developed by...

  • Recombinant Activated Factor VII: Current Perspectives and Epworth Experience Labattaglia, Matthew P.; Ihle, Benno // Heart, Lung & Circulation;Jun2007 Supplement 3, Vol. 16 Issue s3, pS96 

    Recombinant factor VII was first developed for control and prevention of bleeding in haemophilia with antibodies to factor VIII and IX. Its efficacy in these situations is well established. Over recent years, the ‘off-label’ use of this substance has become more widespread in...

  • Bad Blood. Grens, Kerry // Scientist;Nov2013, Vol. 27 Issue 11, p18 

    The article the result of the study conducted by the hematologist in Texas which revealed the clinical assessment of patient with rare bleeding disorder. It examines the region of chromosome 1 which contain the gene for a coagulation factor called factor V (FV). It highlights the role of FV in...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics